tiprankstipranks
ONO Pharmaceutical Co Ltd (JP:4528)
:4528
Japanese Market
4528
ONO Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4528 full AI Analyst Report?

ONO Pharmaceutical Co (4528) Income Statement

1 Followers

ONO Pharmaceutical Co Income Statement

Last quarter (Q1 2026), ONO Pharmaceutical Co's total revenue was ¥127.54B, a decrease of -8.84% from the same quarter last year. In Q1, ONO Pharmaceutical Co's net income was ¥17.59B. See ONO Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 26Mar 25Mar 24Mar 23
Total Revenue
¥ 486.87B¥ 515.78B¥ 502.67B¥ 447.19B¥ 361.36B
Gross Profit
¥ 335.47B¥ 374.07B¥ 372.67B¥ 334.28B¥ 264.91B
Operating Expenses
¥ 272.08B¥ 270.73B¥ 209.10B¥ 181.99B¥ 150.00B
Depreciation and Amortization
¥ 26.89B¥ 37.75B¥ 18.14B¥ 17.45B¥ 17.72B
EBITDA
¥ 90.28B¥ 141.09B¥ 181.70B¥ 169.75B¥ 132.63B
Operating Income
¥ 63.38B¥ 103.33B¥ 163.56B¥ 152.29B¥ 114.91B
Other Income/Expenses
¥ -4.06B¥ -10.68B¥ 173.00M¥ -8.76B¥ -9.89B
Pretax Income
¥ 59.33B¥ 92.65B¥ 163.73B¥ 143.53B¥ 105.03B
Net Income
¥ 50.05B¥ 69.77B¥ 127.98B¥ 112.72B¥ 80.52B
Per Share Metrics
Basic EPS
¥ 106.55¥ 148.49¥ 266.61¥ 230.85¥ 162.19
Diluted EPS
¥ 106.41¥ 148.42¥ 266.57¥ 230.79¥ 162.16
Weighted Average Shares Outstanding
 469.69M 469.85M 480.01M 488.30M 496.46M
Weighted Average Shares Outstanding (Diluted)
 469.77M 469.97M 480.04M 488.35M 496.53M
Currency in JPY

ONO Pharmaceutical Co Earnings and Revenue History